Step by Step

INTRODUCTION

4/26/2016 - Medical Grand Rounds: Rheumatology Year in Review

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Be aware of the new guidelines for treating RA pertaining to the primary care provider.
  • Be aware of new drugs that have been approved for use in the field of rheumatology in 2015.

Suggested Additional Reading:

  1. Tstomu T, et al. Japan College of Rheumatology. 2015, 25 817-824. DOI: 10.3109143975952015.10222297.
  2. Nicholas Wilson et al. Rheumatology 2015;54:860-867.
  3. Long-term Evaluation of Opioid Treatment in Fibromyalgia. Peng, Xiaomei; MD, PhD; Robinson, Rebecca; Mease, Philip; Kroenke, Kurt; Williams, David; Chen, Yi; Faries, Douglas; Wohlreich, Madelaine; McCarberg, Bill; Hann, Danette Clinical Journal of Pain. 31(1):7-13, January 2015. DOI: 10.1097/AJP.0000000000000079
  4. Tyndall AJ Ann Rheum Dis 2010; Steen et al. Arth Rheum 1994; 37:1283-9.
  5. Mayes et al. SystemicSclerosis, 2nd ed., Lipincott, NY, 2004.
  6. Rice et al. J Clin Invest. 2015;125(7);2795-2807.
  7. Perez-Ruiz F, et al. Ann Rheum Dis 2016;0:1–7. doi:10.1136/annrheumdis-2015-207919.

Authors:
Niveditha Mohan, MD — Assistant Professor of Medicine Division of Rheumatology Arthritis and Autoimmunity Center
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Creditâ„¢

The University of Pittsburgh is an affirmative action, equal opportunity institution.